Swiss international biotech giant Roche Holding AG, through its Roche Canada unit, said Tuesday it will invest almost $200 million over the next five years at its Mississauga plant near Toronto, with a $7.8 million Ontario Government commitment. A new Mississauga research centre, with a staff of 200, will manage all Roche’s clinical trials for new drugs in co-operation with the multinational’s five existing world research centres. “This program reflects a shared commitment by Canada’s research-based pharmaceutical industry and the Province of Ontario to build long-term benefits and international leadership in life sciences,” Roche said in a statement.
